February 13, 2017 / 5:16 PM / 6 months ago

BRIEF-Transgene: First patient of ISI-JX trial treated

Feb 13 (Reuters) - Transgene SA :

* Transgene and Leon Berard cancer center announce dosing of the first patient in a phase 1 immunotherapy clinical trial evaluating the intra-tumoral co-administration of Pexa-Vec plus ipilimumab (Yervoy) in solid cancers Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below